“Cognitive enhancement drugs only have short-term benefits and can cause significant side-effects for people with mild memory problems, according to researchers. In a new review of existing data, researchers at St. Michael’s Hospital in Toronto, Canada studied eight randomized clinical trials and three companion reports on the efficacy of four drugs in people with mild cognitive impairment. The drugs were donepezil (Aricept), rivastigmine (Exelon), galantamine (Razadyne), and memantine (Namenda). They found that while the drugs do have short-term benefits, they are lost after a year and a half of treatment.”
Did you like this?
Tip Freedomwat.ch Staff with Bitcoin
Tip Freedomwat.ch Staff with Bitcoin
Related posts:
Mother takes son’s police shooting case to UN Human Rights Committee
Why Buffett Is Betting Big on Housing
California family doctor forced into re-education under new vaccine mandate
Call of Duty loser calls in SWAT team hoax on kid who beat him
Will NYC Get Its First Bitcoin ATM in 2014?
Starting an online store in Greece is no easy business
Irish TD wants tougher controls of online currencies such as Bitcoin
St Lucia considers economic citizenship to boost investment
Stephen Francis Bukucs 'aimed lasers at planes'
Justin Amash amendment to defund the NSA may be circumvented by House leadership
American Automobile Glut? Unsold Cars Are Piling Up
World’s first Bitcoin ATM exceeds $1M in transactions within one month
Fortress’s Novogratz says bitcoin is in ‘inning 3 of a 9 inning game’
Revelations of N.S.A. Spying Cost U.S. Tech Companies
Women in combat no later than 2016, Pentagon says